Kathryn W. Kyle

CIK: 0002103996

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (14.3%)

Position reduction

Option Exercises (M)4 (28.6%)

Derivative conversions

Awards (A)3 (21.4%)

Compensation grants

Other (G, F, J, C, D, …)5 (35.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LABCORP HOLDINGS INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

LH
LABCORP HOLDINGS INC.
Jul 2, 2026
Sale(S)
Direct
92 shares at avg. $286.19$26K
LH
LABCORP HOLDINGS INC.
Jul 1, 2026
Exercise(M)
Direct
256 shares-
LH
LABCORP HOLDINGS INC.
Jul 1, 2026
Tax Payment(F)
Direct
73 shares at avg. $283.88$21K
LH
LABCORP HOLDINGS INC.
Jun 8, 2026
Sale(S)
Direct
762 shares at avg. $263.89$201K
LH
LABCORP HOLDINGS INC.
Mar 26, 2026
Tax Payment(F)
Direct
451 shares at avg. $268.38$121K
LH
LABCORP HOLDINGS INC.
Mar 26, 2026
Award(A)
Direct
1.6K shares-
LH
LABCORP HOLDINGS INC.
Feb 11, 2026
Exercise(M)
Direct
216 shares-
LH
LABCORP HOLDINGS INC.
Feb 11, 2026
Tax Payment(F)
Direct
62 shares at avg. $289.89$18K
LH
LABCORP HOLDINGS INC.
Feb 10, 2026
Award(A)
Non-qualified Stock Options
Direct
2.7K shares-
LH
LABCORP HOLDINGS INC.
Feb 10, 2026
Award(A)
Restricted Stock Unit
Direct
880 shares-
LH
LABCORP HOLDINGS INC.
Feb 9, 2026
Tax Payment(F)
Direct
61 shares at avg. $274.01$17K
LH
LABCORP HOLDINGS INC.
Feb 7, 2026
Exercise(M)
Direct
178 shares-
LH
LABCORP HOLDINGS INC.
Feb 6, 2026
Tax Payment(F)
Direct
61 shares at avg. $277.20$17K
LH
LABCORP HOLDINGS INC.
Feb 6, 2026
Exercise(M)
Direct
180 shares-

		Type	Shares	Price		Ownership
Jul 2, 2026	LH LABCORP HOLDINGS INC.	Sale(S)	92	$286.19	$26,329	Direct
Jul 1, 2026	LH LABCORP HOLDINGS INC.	Exercise(M)	256	-	$0	Direct
Jul 1, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	73	$283.88	$20,723	Direct
Jun 8, 2026	LH LABCORP HOLDINGS INC.	Sale(S)	762	$263.89	$201,084	Direct
Mar 26, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	451	$268.38	$121,039	Direct
Mar 26, 2026	LH LABCORP HOLDINGS INC.	Award(A)	1,584	-	$0	Direct
Feb 11, 2026	LH LABCORP HOLDINGS INC.	Exercise(M)	216	-	$0	Direct
Feb 11, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	62	$289.89	$17,973	Direct
Feb 10, 2026	LH LABCORP HOLDINGS INC.	Award(A) Non-qualified Stock Options	2,700	-	-	Direct
Feb 10, 2026	LH LABCORP HOLDINGS INC.	Award(A) Restricted Stock Unit	880	-	-	Direct
Feb 9, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	61	$274.01	$16,715	Direct
Feb 7, 2026	LH LABCORP HOLDINGS INC.	Exercise(M)	178	-	$0	Direct
Feb 6, 2026	LH LABCORP HOLDINGS INC.	Tax Payment(F)	61	$277.20	$16,909	Direct
Feb 6, 2026	LH LABCORP HOLDINGS INC.	Exercise(M)	180	-	$0	Direct

1-14 of 14 transactions

About Kyle Kathryn W

Kyle Kathryn W (SEC CIK 0002103996) files insider reports with the SEC as EVP, Chief Legal Officer of LABCORP HOLDINGS INC. (LH).

Signal8 holds 7 ownership filings by Kyle Kathryn W (1 Form 3, 6 Form 4), filed between Jan 12, 2026 and Jul 6, 2026. Those filings report 14 transactions, from Feb 6, 2026 to Jul 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kyle Kathryn W's filings is in BURLINGTON, NC.

Recent filings by Kyle Kathryn W

Jul 2, 2026: Open-market sale of LH shares (Form 4, code S).
Jul 1, 2026: Option exercise of LH shares (Form 4, code M).
Jul 1, 2026: Tax withholding of LH shares (Form 4, code F).
Jun 8, 2026: Open-market sale of LH shares (Form 4, code S).
Mar 26, 2026: Tax withholding of LH shares (Form 4, code F).

Other insiders filing for LABCORP HOLDINGS INC. (LH)

Parham Richelle P, Director
Oyegunwa Akinbolade, EVP, CIO & CTO
Vaughn Bryan T, EVP and President, Diagnostics
Meltzer Jonathan C, EVP, COO
Caveney Brian J, EVP, Pres of BLS, CMO & CSO
ANDERSON KERRII B, Director

How to read Form 4 transaction codes